SUSHMA YALAMANCHILI

Concepts (108)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papilledema
4
2016
89
0.640
Why?
Cavernous Sinus Thrombosis
1
2018
8
0.610
Why?
Cellulitis
1
2018
63
0.600
Why?
Scalp
1
2018
59
0.590
Why?
Pseudotumor Cerebri
3
2016
68
0.560
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2018
92
0.550
Why?
Arnold-Chiari Malformation
1
2011
51
0.350
Why?
Magnetic Resonance Imaging
9
2018
3843
0.270
Why?
Optic Nerve
2
2016
123
0.220
Why?
Diagnosis, Differential
4
2018
1971
0.210
Why?
Vision Disorders
2
2017
238
0.200
Why?
Giant Cell Arteritis
2
2019
59
0.170
Why?
Diplopia
1
2019
41
0.150
Why?
Rupture, Spontaneous
1
2018
51
0.150
Why?
Vision, Binocular
1
2019
47
0.150
Why?
Optic Chiasm
1
2018
16
0.150
Why?
Temporal Arteries
1
2019
40
0.150
Why?
Optic Nerve Neoplasms
1
2018
20
0.150
Why?
Visual Acuity
3
2019
864
0.150
Why?
Retinal Artery
1
2017
17
0.140
Why?
Eye Foreign Bodies
1
2017
15
0.140
Why?
Metals
1
2017
64
0.140
Why?
Subarachnoid Hemorrhage
1
2017
71
0.140
Why?
Acetazolamide
1
2016
31
0.130
Why?
Carbonic Anhydrase Inhibitors
1
2016
28
0.130
Why?
Central Nervous System Neoplasms
1
2018
216
0.120
Why?
Lymphoma
1
2018
335
0.120
Why?
Horner Syndrome
1
2015
14
0.120
Why?
Embolization, Therapeutic
1
2017
224
0.120
Why?
Neuromyelitis Optica
2
2012
34
0.110
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
178
0.110
Why?
Cerebral Ventricle Neoplasms
1
2014
16
0.110
Why?
Third Ventricle
1
2014
33
0.110
Why?
Cerebrospinal Fluid Shunts
1
2014
95
0.110
Why?
Pelvic Floor
1
2013
37
0.110
Why?
Pelvic Organ Prolapse
1
2013
29
0.100
Why?
Choroid
1
2013
43
0.100
Why?
Career Choice
1
2014
161
0.100
Why?
Tomography, X-Ray Computed
2
2018
2196
0.100
Why?
Peripheral Vascular Diseases
1
2013
87
0.100
Why?
Optic Neuropathy, Ischemic
1
2013
48
0.100
Why?
Retinitis
1
2012
18
0.100
Why?
Neurology
1
2014
120
0.100
Why?
Cat-Scratch Disease
1
2012
32
0.100
Why?
Optic Atrophy, Hereditary, Leber
1
2012
15
0.100
Why?
Behavioral Symptoms
1
2012
25
0.090
Why?
Ophthalmology
1
2014
217
0.090
Why?
Paraneoplastic Syndromes
1
2010
19
0.090
Why?
Image Processing, Computer-Assisted
1
2013
623
0.090
Why?
Carcinoma, Small Cell
1
2010
50
0.090
Why?
Optic Neuritis
1
2011
35
0.090
Why?
Education, Medical
1
2014
304
0.090
Why?
Adult
8
2018
31928
0.080
Why?
Biopsy
3
2019
1304
0.080
Why?
Optic Nerve Diseases
1
2010
94
0.080
Why?
Glioma
1
2014
534
0.080
Why?
Humans
18
2019
133809
0.070
Why?
Autoantibodies
1
2010
466
0.070
Why?
Tomography, Optical Coherence
3
2017
584
0.060
Why?
Renal Dialysis
1
2013
875
0.060
Why?
Male
9
2019
65830
0.060
Why?
Female
11
2019
71587
0.060
Why?
Middle Aged
6
2018
29350
0.060
Why?
Fluorescein Angiography
2
2017
155
0.060
Why?
Lung Neoplasms
1
2010
1792
0.040
Why?
Blood Sedimentation
1
2019
30
0.040
Why?
Follow-Up Studies
2
2019
5503
0.030
Why?
Aged
4
2019
21701
0.030
Why?
Visual Field Tests
1
2016
54
0.030
Why?
C-Reactive Protein
1
2019
472
0.030
Why?
Spinal Puncture
1
2016
54
0.030
Why?
Adenine
1
2016
122
0.030
Why?
Clonidine
1
2015
37
0.030
Why?
Dopamine Uptake Inhibitors
1
2015
37
0.030
Why?
Visual Fields
1
2016
150
0.030
Why?
Adrenergic alpha-2 Receptor Agonists
1
2015
27
0.030
Why?
Antimetabolites, Antineoplastic
1
2016
197
0.030
Why?
Piperidines
1
2016
238
0.030
Why?
Administration, Oral
1
2016
730
0.030
Why?
New York
1
2013
73
0.030
Why?
Methotrexate
1
2016
355
0.030
Why?
Retrospective Studies
3
2019
17457
0.030
Why?
Cocaine
1
2015
210
0.030
Why?
Craniotomy
1
2014
109
0.030
Why?
Pyrazoles
1
2016
327
0.030
Why?
Observer Variation
1
2013
314
0.030
Why?
Aged, 80 and over
2
2015
7194
0.020
Why?
Pyrimidines
1
2016
417
0.020
Why?
Bartonella henselae
1
2012
19
0.020
Why?
Prednisone
1
2013
290
0.020
Why?
Azithromycin
1
2012
47
0.020
Why?
Drug Therapy, Combination
1
2016
1198
0.020
Why?
Cost-Benefit Analysis
1
2015
567
0.020
Why?
Neuroimaging
1
2015
372
0.020
Why?
Diagnostic Techniques, Ophthalmological
1
2012
105
0.020
Why?
Glucocorticoids
1
2013
408
0.020
Why?
Immunoglobulin G
1
2012
823
0.020
Why?
Prognosis
1
2019
5068
0.020
Why?
Child
3
2015
25743
0.020
Why?
Infant
2
2015
13148
0.020
Why?
Child, Preschool
2
2015
14787
0.020
Why?
Multiple Sclerosis
1
2011
392
0.020
Why?
Prevalence
1
2013
2655
0.020
Why?
Kidney Failure, Chronic
1
2013
911
0.020
Why?
Severity of Illness Index
1
2013
3064
0.010
Why?
Adolescent
2
2015
20542
0.010
Why?
Anti-Bacterial Agents
1
2012
2515
0.010
Why?
Young Adult
1
2013
9902
0.010
Why?
YALAMANCHILI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (108)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_